198 related articles for article (PubMed ID: 2465574)
41. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
[TBL] [Abstract][Full Text] [Related]
42. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
43. [Prognostic factors in kidney cancer].
Patard JJ
Prog Urol; 2007 Feb; 17(1 Suppl 1):139-43. PubMed ID: 17571637
[No Abstract] [Full Text] [Related]
44. Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.
Negrier S; Maral J; Drevon M; Vinke J; Escudier B; Philip T
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S93-8. PubMed ID: 10685667
[TBL] [Abstract][Full Text] [Related]
45. Treatment of metastatic renal cell carcinoma.
Reeves DJ; Liu CY
Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348
[TBL] [Abstract][Full Text] [Related]
46. Neoadjuvant treatment of renal cell carcinoma.
Rathmell WK; Pruthi R; Wallen E
Urol Oncol; 2010; 28(1):69-73. PubMed ID: 20123351
[TBL] [Abstract][Full Text] [Related]
47. Adjuvant therapy of renal cell carcinoma.
Yap TA; Eisen TG
Clin Genitourin Cancer; 2006 Sep; 5(2):120-30. PubMed ID: 17026800
[TBL] [Abstract][Full Text] [Related]
48. [Biologic response modifiers in the treatment of solid tumors].
Tagliaferri F; Lucandri G; Stipa F; Stipa S
Recenti Prog Med; 1991 Jun; 82(6):352-8. PubMed ID: 1718019
[TBL] [Abstract][Full Text] [Related]
49. Interferons in renal-cell carcinoma: status and prospects.
De Mulder PH; Debruyne FM; Beniers AJ
Prog Clin Biol Res; 1990; 348():49-59. PubMed ID: 1696737
[No Abstract] [Full Text] [Related]
50. The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma.
Figlin RA; Abi-Aad AS; Belldegrun A; deKernion JB
Semin Oncol; 1991 Oct; 18(5 Suppl 7):102-7. PubMed ID: 1719641
[TBL] [Abstract][Full Text] [Related]
51. [New therapeutic opportunities in metastatic renal cell carcinoma].
Buess M
Praxis (Bern 1994); 2009 Apr; 98(9):481-6. PubMed ID: 19404907
[TBL] [Abstract][Full Text] [Related]
52. Removing the primary tumor after the cancer has spread.
Tannock IF
N Engl J Med; 2001 Dec; 345(23):1699-700. PubMed ID: 11759650
[No Abstract] [Full Text] [Related]
53. [Systemic treatment of renal-cell carcinoma--present status].
Steiner T; Schubert J
Dtsch Med Wochenschr; 2001 Sep; 126(39):1080-4. PubMed ID: 11602916
[No Abstract] [Full Text] [Related]
54. Interferons and interleukins in metastatic renal cell carcinoma.
Choudhury M; Efros M; Mittelman A
Urology; 1993 Jan; 41(1 Suppl):67-72. PubMed ID: 7678365
[TBL] [Abstract][Full Text] [Related]
55. Role of interferons in the therapy of metastatic renal cell carcinoma.
Quesada JR
Urology; 1989 Oct; 34(4 Suppl):80-3; discussion 87-96. PubMed ID: 2678687
[TBL] [Abstract][Full Text] [Related]
56. The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy.
Rini BI; Campbell SC
J Urol; 2007 Jun; 177(6):1978-84. PubMed ID: 17509276
[TBL] [Abstract][Full Text] [Related]
57. [Therapeutic options in metastatic renal carcinoma].
Fernández Aparicio T; Miñana López B; Carrero V; Caballero J; Vazquez S; Calahorra L; Leiva O
Actas Urol Esp; 1992 Jul; 16(7):529-39. PubMed ID: 1442223
[TBL] [Abstract][Full Text] [Related]
58. [Spontaneous remission of lung metastases in renal cell carcinoma].
Müller GA; Diem U; Fritz U; Walter E; Waller HD
Dtsch Med Wochenschr; 1989 Mar; 114(11):420-3. PubMed ID: 2523299
[TBL] [Abstract][Full Text] [Related]
59. The current use of interferons, interleukin-2 and tumor necrosis factor in renal cell cancer.
Wirth M
Urol Int; 1991; 47(4):219-30. PubMed ID: 1723554
[TBL] [Abstract][Full Text] [Related]
60. Medical treatment of advanced renal cell carcinoma: present options and future directions.
Canobbio L; Miglietta L; Boccardo F
Cancer Treat Rev; 1996 Mar; 22(2):85-104. PubMed ID: 8665566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]